Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype
Journal of Clinical Oncology · 10.02.2023 · 41 (5) · 1059-1068
DOI: 10.1200/jco.22.01424 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 10.02.2023. Verfasst von Camryn M Cohen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Uterine Cervical Neoplasms. Die Arbeit wurde bisher 154-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
PURPOSE We conducted an integrated population-based analysis of histologic subtype–specific cervical cancer incidence, survival, and incidence-based mortality by race and ethnicity, with correction for hysterectomy prevalence. METHODS Using the SEER 21 and 18 registries, we selected primary cases of malignant cervical cancer diagnosed among women ≥ 15 years. We evaluated age-adjusted incidence rates among cases diagnosed between 2000 and 2018 (SEER21) and incidence-based mortality rates among deaths from 2005 to 2018 (SEER18), per 100,000 person-years. Rates were stratified by histologic subtype and race/ethnicity (incidence and mortality), and stage, age at diagnosis, and county-level measures of social determinants of health (incidence only). Incidence and mortality rates were corrected for hysterectomy using data from the Behavioral Risk Factor Surveillance System. We estimated 5-year relative survival by histologic subtype and stratified by stage at diagnosis. RESULTS Incidence rates of cervical squamous cell carcinoma were highest in Black and Hispanic women, while incidence rates of cervical adenocarcinoma (ADC) were highest among Hispanic and White women, particularly for localized ADC. County-level income and education variables were inversely associated with squamous cell carcinoma incidence rates in all racial and ethnic groups but had less influence on ADC incidence rates. Black women had the highest overall mortality rates and lowest 5-year relative survival, irrespective of subtype and stage. Disparities in survival were particularly pronounced for Black women with regional and distant ADC, compared with other racial/ethnic groups. CONCLUSION Although Black women are less likely to be diagnosed with ADC compared with all other racial/ethnic groups, they experience the highest mortality rates for this subtype, likely attributed to the poor survival observed for Black women with regional and distant ADC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Cancer Epidemiology & Genetics, National Cancer Institute, Rockville, MD.
- Division of Cancer Prevention, National Cancer Institute, Rockville, MD.
- Department of Pathology, College of Medicine, University of Oklahoma, Oklahoma City, OK.
- Department of Obstetrics and Gynecology, University of Alabama at Birmingham, Birmingham, AL.
ORCID-Profile: Camryn M Cohen, Nicolas Wentzensen, Philip E Castle, Megan A Clarke
Förderung
- NCI NIH HHS
- Intramural NIH HHS
Zitieren
APA
Cohen, C. M., Wentzensen, N., Castle, P. E., Schiffman, M., Zuna, R., Arend, R. C., & Clarke, M. A. (2023). Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype. Journal of Clinical Oncology, 41(5), 1059-1068. https://doi.org/10.1200/jco.22.01424
Vancouver
Cohen CM, Wentzensen N, Castle PE, Schiffman M, Zuna R, Arend RC, et al. Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype. Journal of Clinical Oncology. 2023;41(5):1059-1068. doi:10.1200/jco.22.01424
BibTeX
@article{Cohen2023,
author = {Cohen, Camryn M and Wentzensen, Nicolas and Castle, Philip E and Schiffman, Mark and Zuna, Rosemary and Arend, Rebecca C and Clarke, Megan A},
title = {Racial and Ethnic Disparities in Cervical Cancer Incidence, Survival, and Mortality by Histologic Subtype},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {5},
pages = {1059--1068},
doi = {10.1200/jco.22.01424}
}
EUVIMED